{"entity":{"id":"nct06345482","kind":"trial","name":"A Study of MHB039A for Advanced Solid Tumor","aka":[],"tldr":"A phase 1/2 trial of MHB039A in advanced solid tumours, run by Minghui Pharmaceutical (Hangzhou) Ltd, active and no longer recruiting.","summary":"A Study of MHB039A for Advanced Solid Tumor is a phase 1/2 interventional study registered as NCT06345482 by Minghui Pharmaceutical (Hangzhou) Ltd, with 196 participants enrolled, started 2024-04-16 and due to reach its primary completion in 2028-04-01. Interventions recorded: MHB039A.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06345482","url":"https://clinicaltrials.gov/study/NCT06345482"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06345482","phase":"1/2","setting":"A Phase I/II Study of MHB039A for Advanced Solid Tumor to Evaluate the Efficacy and Safety","sponsor":"Minghui Pharmaceutical (Hangzhou) Ltd","enrolled":196,"outcomes":[]},"route":"/trials/nct06345482/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"mhb039a","kind":"drug","name":"MHB039A","route":"/drugs/mhb039a/"}]}}